---

Morgan Craig

Group Leader: Quantitative and Translational Medicine Laboratory @ Sainte-Justine University Hospital Research Centre and Université de Montréal

Montréal, Canada

Twitter: @lab_craig
Website: http://morgancraiglab.com

Keywords (click a keyword to view other similar labs):
theoretical • immune interactions in cancer • personalized medicine • treatment optimization • immunotherapies • in silico clinical trials.

Description: The Quantitative and Translational Medicine Laboratory focuses on the application and implementation of quantitative approaches, particularly computational biology, to study how heterogeneity impacts on disease and treatment outcomes. Our research focuses on the development of predictive, mechanistic models of cancer (both solid and liquid tumours) and viral respiratory diseases to identify pathophysiological mechanisms and tailor therapeutic regimens according to patient-specific characteristics using in silico clinical trials and virtual patient cohorts.

---

Follow Morgan Craig on Twitter: @lab_craig.

Blog posts written by Morgan Craig:

Browse the article contributions of Morgan Craig below or browse the full blog here.

What does heterogeneity mean for cancer treatment models?

Behind the papers

Written by Morgan Craig on November 09, 2020

---

Artwork by Morgan Craig:

Each week, we feature cover artwork submitted by mathematical oncology researchers around the world. Browse the contributions of Morgan Craig below. Click to expand each cover, or browse the full collection here.

Issue 215

"Glioblastoma is the most common adult brain tumour. Its aggressive nature makes it difficult to treat successfully. In our study,..."

View this issue on Substack
View full size

Issue 212

"Glioblastoma is a complex disease that is difficult to treat. In our study, we applied a host of data theoretic..."

View this issue on Substack
View full size